{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T04:40:08Z","timestamp":1731732008605,"version":"3.28.0"},"reference-count":37,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,11,15]]},"DOI":"10.2169\/internalmedicine.2888-23","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T22:12:04Z","timestamp":1712009524000},"page":"3093-3100","source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune Encephalitis in a Patient with a Solitary Intracranial Plasmacytoma"],"prefix":"10.2169","volume":"63","author":[{"given":"Keisuke","family":"Mizutani","sequence":"first","affiliation":[{"name":"Department of Neurology, Toyokawa City Hospital, Japan"},{"name":"Department of Neurology, Tosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Radiology, National Center for Geriatrics and Gerontology, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Uchida","sequence":"additional","affiliation":[{"name":"The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, USA"},{"name":"Department of Neurology and Neuroscience, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Tosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Kajiguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Tosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukitoshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"National Epilepsy Center, NHO Shizuoka Institute of Epilepsy and Neurological Disorders, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yuasa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tosei General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Takada","sequence":"additional","affiliation":[{"name":"Department of Neurology, Toyokawa City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Matsukawa","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neuroscience, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15: 391-404, 2016.","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 349: 1543-1554, 2003.","DOI":"10.1056\/NEJMra023009"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rosenfeld MR, Dalmau J. Paraneoplastic neurologic syndromes. Neurol Clin 36: 675-685, 2018.","DOI":"10.1016\/j.ncl.2018.04.015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 8: e1014, 2021.","DOI":"10.1212\/NXI.0000000000001014"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Flanagan EP. Paraneoplastic disorders of the nervous system. J Neurol 268: 4899-4907, 2021.","DOI":"10.1007\/s00415-021-10570-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fujita K, Yuasa T, Takahashi Y, et al. Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients. J Neuroimmunol 251: 90-93, 2012.","DOI":"10.1016\/j.jneuroim.2012.06.010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cope TE, Breen DP, Chawda S, Cifelli A. Anti-collapsin response mediator protein 5 encephalitis masquerading as a low-grade brain tumour. Pract Neurol 16: 376-380, 2016.","DOI":"10.1136\/practneurol-2016-001379"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zhang Z, Fan S, Ren H, Zhou L, Guan H. Clinical characteristics and prognosis of anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis. BMC Neurol 21: 490, 2021.","DOI":"10.1186\/s12883-021-02520-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sobol U, Stiff P. Neurologic aspects of plasma cell disorders. Handb Clin Neurol 120: 1083-1099, 2014.","DOI":"10.1016\/B978-0-7020-4087-0.00073-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pearce JM. Paraneoplastic limbic encephalitis. Eur Neurol 53: 106-108, 2005.","DOI":"10.1159\/000085512"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sun X, Tan J, Sun H, et al. anti-SOX1 antibodies in paraneoplastic neurological syndrome. J Clin Neurol 16: 530-546, 2020.","DOI":"10.3988\/jcn.2020.16.4.530"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nwabuobi LA, Pellinen JC, Wisniewski TM. Thymoma-associated panencephalitis: a newly emerging paraneoplastic neurologic syndrome. Neuroimmunol Neuroinflamm 4: 117-123, 2017.","DOI":"10.20517\/2347-8659.2016.53"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yoshino A, Kimura Y, Miyazaki M, et al. Limbic encephalitis with autoantibodies against the glutamate receptor epsilon 2 mimicking temporal lobe epilepsy. Psychiatry Clin Neurosci 61: 335, 2007.","DOI":"10.1111\/j.1440-1819.2007.01669.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld JR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10: 63-74, 2011.","DOI":"10.1016\/S1474-4422(10)70253-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mauermann ML. Paraporteinemic neuropathies. Continuum (Minneap Minn) 20: 1307-1322, 2014.","DOI":"10.1212\/01.CON.0000455879.99050.26"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Drappatz J, Batchelor T. Neurologic complications of plasma cell disorders. Clin Lymphoma 5: 163-171, 2004.","DOI":"10.3816\/CLM.2004.n.022"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dubey D, Honorat JA, Shelly S, et al. Contactin-1 autoimmunity: serologic, neurologic, and pathologic correlates. Neurol Neuroimmunol Neuroinflamm 7: e771, 2020.","DOI":"10.1212\/NXI.0000000000000771"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Bruyn GA, Zwetsloot CP, van Nieuwkoop JA, den Ottolander GJ, Padberg GW. Cranial nerve palsy as the presenting feature of secondary plasma cell leukemia. Cancer 60: 906-909, 1987.","DOI":"10.1002\/1097-0142(19870815)60:4<906::AID-CNCR2820600432>3.0.CO;2-V"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. G\u00fcne\u015f HN, Bileceno\u011flu NT, \u015eener U, Yolda\u015f TK. POEMS syndrome with peripheral and central nervous system demyelination: case report. Neurologist 19: 101-103, 2015.","DOI":"10.1097\/NRL.0000000000000017"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Fu FW, Rao J, Zheng YY, Wang HL, Yang JG, Zheng GQ. Ischemic stroke in patients with POEMS syndrome: a case report and comprehensive analysis of literature. Oncotarget 24: 89406-89424, 2017.","DOI":"10.18632\/oncotarget.20131"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Takahashi Y, Nishimura S, Takao E, et al. Characteristics of internalization of NMDA-type GluRs with antibodies to GluN1 and GluN2B. J Neuroimmunol 349: 577427, 2020.","DOI":"10.1016\/j.jneuroim.2020.577427"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Varadkar S, Bien CG, Kruse CA, et al. Rasmussen&apos;s encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol 13: 195-205, 2014.","DOI":"10.1016\/S1474-4422(13)70260-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yamaguchi Y, Wada M, Kurita K, Takahashi Y, Kato Y. Case of acute limbic encephalitis associated with SLE accompanied with anti-glutamate receptor antibodies. Rinsho Shinkeigaku (Clin Neurol) 52: 545-550, 2012.","DOI":"10.5692\/clinicalneurol.52.545"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Masuda T, Kimura N, Ishibashi M, Ito M, Takashi Y, Kumamoto T. Case of Vogt-Koyanagi-Harada disease associated with non-herpetic acute limbic encephalitis with autoantibodies against glutamate receptor \u03b52 in the cerebrospinal fluid. Rinsho Shinkeigaku (Clin Neurol) 49: 483-487, 2009.","DOI":"10.5692\/clinicalneurol.49.483"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nishiguchi R, Fujimoto T, Eguchi K, Fukuda Y, Takahashi Y. A case of bilateral auricular chondritis with anti-glutamate receptor (GluR\u03b52) antibody-positive non-herpetic acute limbic encephalitis. Rinsho Shinkeigaku (Clin Neurol) 55: 395-400, 2015.","DOI":"10.5692\/clinicalneurol.cn-000644"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kashihara K, Kawada S, Takahashi Y. Autoantibodies to glutamate receptor GluR\u03b52 in patient with limbic encephalitis associated with relapsing polychondritis. J Neurol Sci 287: 275-277, 2009.","DOI":"10.1016\/j.jns.2009.08.004"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tsukita K, Shimotake A, Nakatani M, Takahashi Y, Ikeda A, Takahashi R. A case of neurosyphilis presenting with limbic encephalitis. Rinsho Shinkeigaku (Clin Neurol) 57: 37-40, 2017.","DOI":"10.5692\/clinicalneurol.cn-000936"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Nakajima H, Hosoya M, Takahashi Y, et al. A chronic progressive case of enteroviral limbic encephalitis associated with autoantibody to glutamate receptor \u03b52. Eur Neurol 57: 238-240, 2007.","DOI":"10.1159\/000101289"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kimura A, Sakurai T, Suzuki Y, et al. Autoantibodies against glutamate receptor \u03b5<sub>2<\/sub>-subunit detected in a subgroup of patients with reversible autoimmune limbic encephalitis. Eur Neurol 58: 152-158, 2007.","DOI":"10.1159\/000104716"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Samejima S, Tateishi T, Arahata H, Shigeto H, Ohyagi Y, Kira J. A case of anti-Hu antibody- and anti-GluR \u03b52 antibody-positive paraneoplastic neurological syndrome presenting with limbic encephalitis and peripheral neuropathy. Rinsho Shinkeigaku (Clin Neurol) 50: 467-472, 2010.","DOI":"10.5692\/clinicalneurol.50.467"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Takahashi Y, Mori H, Mishina M, et al. Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua. Neurology 61: 891-896, 2003.","DOI":"10.1212\/01.WNL.0000086819.53078.70"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75: 1135-1140, 2004.","DOI":"10.1136\/jnnp.2003.034447"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Gilligan M, McGuigan C, KcKeon A. Paraneoplastic neurologic disorders. Curr Neurol Neurosci Rep 23: 67-82, 2023.","DOI":"10.1007\/s11910-023-01250-w"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev 97: 839-887, 2017.","DOI":"10.1152\/physrev.00010.2016"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. McKeon A, Pittock SJ. Paraneoplastic encephalomyelopathies: pathology and mechanisms. Acta Neuropathol 122: 381-400, 2011.","DOI":"10.1007\/s00401-011-0876-1"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Groc L, Heine M, Cousins SL, et al. NMDA receptor surface mobility depends on NR2A-2B subunits. Proc Natl Acad Sci U S A 103: 18769-18774, 2006.","DOI":"10.1073\/pnas.0605238103"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Shan F, Long Y, Qiu W. Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. Front Immunol 9: 2802, 2018.","DOI":"10.3389\/fimmu.2018.02802"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/22\/63_2888-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T03:30:50Z","timestamp":1731727850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/22\/63_2888-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":37,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2888-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"article-number":"2888-23"}}